Immune Design
Immune Design develops immunotherapy product candidates for the treatment of cancer and chronic diseases.
Business Model:
Revenue: $2.2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Immune Design Information
Immune Design was acquired by
Merck Sharp &a; Dohme Sweden AB.
The acquisition happend on 2019-02-21.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1616 Eastlake Avenue East
City: Seattle
State: WA
Zip: 98102
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$80M
Raised Total:$161M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Immune Design develops immunotherapy product candidates for the treatment of cancer and chronic diseases.
Contact Phone:
+12066820645
Contact Email:
Immune Design went public on 7/15/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/15/2014
Ticker Symbol:
IMDZ
Amount Raised:
$60M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
